From: Sporadic inclusion body myositis: the genetic contributions to the pathogenesis
Study | Region | Diagnostic criteria | Prevalence (per million population) | Prevalence > 50 yrs (per million population) |
---|---|---|---|---|
Lingberg et al.[2] | Sweden | Biopsy and clinical data | 2.2 | n/a |
Kaipiainen-Seppanen and Aho[4] | Finland | Not mentioned | 0.9 | n/a |
Philips et al.[5] | Australia | Griggs et al. criteria | 9.3 | 35.3 |
Badrising et al.[3] | Netherlands | ENMC criteria | 4.9 | 16 |
Felice and North (Connecticut, USA)[6] | Connecticut, USA | Griggs et al. criteria | 10.7 | 28.9 (>45Â yrs) |
Needham et al.[1] | Western Australia | Clinical and biopsy criteria | 14.9 | 51.2 |
Wilson et al.[7] | Olmsted County, USA | Griggs et al. criteria | 71 | n/a |
Oflazer et al.[8] | Istanbul, Turkey | Own criteria from the study (biopsy and clinical data) | 1.0 | 6.0 |
Suzuki et al.[9] | Japan | Clinical and biopsy criteria | 1.3 (in 1991) | n/a |
9.8 (in 2003) | n/a | |||
Tan et al.[10] | South Australia | Biopsy and clinical data | 50.5 | 139.3 |